Back in January, I wrote about Apple co-founder and CEO Steve Jobs - and his courageous battle against health problems and snippety investors.
On Wednesday, Janet Blake reported with the Associated Press that sources from the Wall Street Journal maintain that Jobs "appears to be a step closer to returning to work," after what appears to be a wonderful recovery from a much-needed liver transplant.
Dr. James D. Eason, chief of transplantation at Methodist University Hospital Transplant Institute in Memphis, commented to the AP that "Mr. Jobs is now recovering well and has an excellent prognosis" after the transplant that was alleged to have taken place about two months ago.
Jobs, who has been on a medical leave for about five months, is at this point, expected to return to Apple in June. That was the initially reported return date back in February - and it seems to be holding true.
Apple did not confirm the report made by the WSJ, a source that has been suggesting details of Jobs' health since August 2004.
I suppose it just goes to show that detrimental and needless gossip isn't bound to teens... according to the AP:
"Investors sent the stock tumbling 5 percent to its lowest point in a year on a rumor last October that Jobs had suffered a heart attack. Then shares slipped 2 percent in December when Apple said that Jobs would not speak as usual the next month at the annual Macworld conference, then bounced up 4 percent on Jan. 5 when Jobs explained his weight loss as a treatable hormone imbalance. They sank 7 percent a week later after Apple said he would be taking six months off because his medical problems were more complex than he initially thought."
Thankfully, Jobs is said to be "in end-stage liver disease," which should (hopefully) put an end to the Apple stock fluctuation that's rooted, it seems, in gossip about his health.
Lastly, Blake reported that today, Apple stock is up to $135 in premarket trading, up from a 52-week low of $78.20 back in late January.
Talk back - leave a comment
